StemCell Institute Inc. (TYO:7096)
Japan
· Delayed Price · Currency is JPY 911.00
-34.00 (-3.60%)
Jul 7, 2025, 3:30 PM JST
StemCell Institute Revenue
In the fiscal year ending March 31, 2025, StemCell Institute had annual revenue of 2.68B JPY with 7.98% growth. StemCell Institute had revenue of 639.00M in the quarter ending March 31, 2025, with 7.04% growth.
Revenue
2.68B
Revenue Growth
+7.98%
P/S Ratio
3.61
Revenue / Employee
22.90M
Employees
117
Market Cap
9.68B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |